miPROLEPSIS
Keywords: Digital biomarkers, Digital health solution, Mobile health app, Psoriatic arthritis
Type
Digital solution and service (e.g. application/digital health portal/platform/AI based system/etc.)
Mobile app
Short description
The miPROLEPSIS app facilitates the iPROLEPSIS-PDPID multicenter clinical study as a data collection tool that will enable the development of digital biomarkers for psoriatic arthritis symptoms and predictive models for inflammation exacerbation. More specifically, the app performs (i) passive data collection from the sensors of the smartwatch used in the study (i.e., Garmin Vivoactive 5), (ii) passive data collection from the accelerometer and gyroscope sensors of the smartphone, (iii) patient reported outcomes via questionnaires. Moreover, the app includes (i) a custom keyboard that captures the user’s typing dynamics and (ii) photo- and video-based activities for the collection of hand/feet photos and skeletal data related to joints flexibility, respectively. Note: The app can be used only by psoriatic arthritis patients that have enrolled to the PDPID study.
Evidence
No impact-related evidence is currently available
Maturity
Proof of concept is available: it works in a test setting and the potential end-users are positive about the concept
TRL 4 (technology validated in lab)
Countries
Greece
Netherlands
Portugal
United Kingdom (please specify)
Netherlands
Portugal
United Kingdom (please specify)
Geographical scope
European
Language(s)
Greek, Dutch, Portuguese and English
Comment
n/a
Submitted in other database or repository of digital health resources that is publicly available
https://play.google.com/store/apps/details?id=com.iprolepsis.patient.app
Additional information
Relations
to clinicians / care practitioners
Health data analytics (Artificial Intelligence/algorithm development and calibration/machine learning/risk stratification tools/etc.)